Peer-reviewed veterinary case report
Lifetime survival of dogs with portosystemic vascular anomalies
By Center, Sharon A et al.·Published in Journal of the American Veterinary Medical Association·2026·College of Veterinary Medicine, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Lifetime survival: surgical versus medical management of portosystemic vascular anomalies in dogs with and without copper-restricted liver diets (1980-2015).
- Species:
- dog
Plain-English summary
A group of dogs with portosystemic vascular anomalies (PSVA), a condition affecting blood flow in the liver, were studied to see how different treatments and diets affected their survival. Dogs that underwent complete surgical ligation had the longest lifespans, averaging over 12 years, while those managed with medication alone lived around 9 years. Interestingly, dogs on a copper-restricted diet (with low copper levels) did just as well as those who had partial surgery. This suggests that a low-copper diet is safe and beneficial for dogs with this condition, helping them live longer, healthier lives.
People also search for: dog liver disease treatment · portosystemic shunt diet · copper-restricted diet for dogs
Abstract
OBJECTIVE: Investigate lifetime survival of dogs with portosystemic vascular anomalies (PSVA) fed copper (Cu)-restricted liver diets (0.10 to 0.12 mg of Cu/100 kcal, below National Research Council and Association of American Feed Control Officials thresholds) with different managerial strategies (complete ligation, partial ligation, or medical management). METHODS: 377 dogs with extrahepatic PSVA (E-PSVA) and 87 with intrahepatic PSVA (I-PSVA) managed at a single specialty hospital (January 15, 1980, to December 28, 2015) were categorized by managerial strategy and dietary Cu intake (Cu-restricted [0.10 to 0.12 mg of Cu/100 kcal] vs Cu-replete [≥ 0.20 mg of Cu/100 kcal]). Lifetime physical, hematological, and death-associated covariates were inspected for evidence of Cu insufficiency. Survival metrics (last age, survival duration, Kaplan-Meier analytics) were compared. Liver Cu was quantified in 71 of 246 biopsies. RESULTS: No evidence of Cu insufficiency was associated with dietary Cu restriction. Extrahepatic PSVA survival age exceeded that of I-PSVA (10.3 vs 6.5 years), and complete ligation survival age exceeded that of partial ligation (E-PSVA, 12.5 vs 10.5 years; I-PSVA, 12.0 vs 6.6 years). Survival age of complete and partial ligation exceeded unstratified medically managed dogs (E-PSVA, 9.1 years; I-PSVA, 5.0 years); however, survival age of Cu-restricted medically managed dogs (E-PSVA, 9.7 years; I-PSVA, 6.5 years) did not differ from those that underwent partial ligation. Pathologic liver Cu accumulation occurred in 9 of 30 (30%) biopsies from dogs fed ≥ 0.40 mg of Cu/100 kcal. CONCLUSIONS: Copper restriction of 0.10 to 0.12 mg/100 kcal is nutritionally sufficient for dogs with PSVA. While complete ligation achieves best survival, partial ligation and medical management with Cu-restricted prescription liver diets can achieve substantial longevity. Liver Cu accumulation occurred only with diets with ≥ 0.40 mg of Cu/100 kcal. CLINICAL RELEVANCE: Cu nutritional adequacy, despite intake below regulatory thresholds, warrants reconsideration of current limits. Case-based data provide a survival reference for canine PSVA with different managerial strategies and confirm risk for liver Cu accumulation with a dietary intake of ≥ 0.40 mg of Cu/100 kcal.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41275594/